N-Hydroxysuccinimide Comprehensive Study by Application (Pharmaceuticals, Cosmetics, Chemicals), Purity (97%, >98%, Others) Players and Region - Global Market Outlook to 2027

N-Hydroxysuccinimide Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
N-Hydroxysuccinimide is a white solid used as a reagent in peptide synthesis. It can be used in the synthesis of N-Hydroxysuccinimide ester via dehydration in presence of a catalyst. Along with this, it is also used in different bioconjugation techniques, such as surface activation of chromatographic supports, protein labelling by fluorescent dyes and enzymes, microbeads, nanoparticles, and microarray slides. Growing popularity of the compound in cosmetics in its ester form in reducing pigmentation is driving the growth of N-Hydroxysuccinimide market.

Highlights from N-Hydroxysuccinimide Market Study
AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


The key Vendors profiled in the report are Apollo Scientific Ltd (United Kingdom), Alfa Aesar, (Thermo Fisher Scientific) (United States), Capot Chemical Co., Ltd. (China), Glentham Life Sciences Ltd (United Kingdom), VWR International, LLC. (United States), Actylis (United States), Suzhou Highfine Biotech Co., Ltd (China), RX Chemicals (India), Glentham Life Sciences Ltd (United Kingdom), Jigs Chemical Limited (India), AdipoGen Life Sciences (Switzerland) and Hefei Home Sunshine Pharmaceutical Technology Co., Ltd (China).

Geographic Breakdown and Segment Analysis
The Global N-Hydroxysuccinimide market presents a comprehensive analysis of the N-Hydroxysuccinimide market by end-user/application (Pharmaceuticals, Cosmetics and Chemicals), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global N-Hydroxysuccinimide industry. Investors and Vendors can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the N-Hydroxysuccinimide market

Analyst at AMA have segmented the market study of Global N-Hydroxysuccinimide market by Type, Application and Region.

Influencing Trend:
Surge in Need for Quality Cosmetics Products

Market Growth Drivers:
Rising Disposable Income of the Global Population and Growing Demand for Eye Care Creams

Challenges:
Complications Associated with Use of N-Hydroxysuccinimide in Peptide Synthesis

Restraints:
Use of Large Amounts of Highly Hazardous Reagents and Solvents in Peptide Synthesis

Opportunities:
Increased Usage of Synthetic Peptides in Cosmetics for Sensitive Skin

On 31st march 2021, Merck formed a strategic partnership with the Faculty of Mathematics and Natural Sciences, Universitas Indonesia (FMIPA-UI) in order to establish the first Collaboration Laboratory between the company and the university. Through this collaboration, the company aimed to advance life science research and innovation development in Indonesia.



Several large and small industry players participate extensively in environmentally sustainable tactics in order to manufacture N-Hydroxysuccinimide and enhance their manufacturing capabilities by leveraging modern production technology. Numerous collaboration and partnerships with the government pertaining to N-Hydroxysuccinimide production also aids in strengthening the market competencies of the key players. This offers them a competitive edge to sustain their market position.

Key Target Audience
Chemical Manufacturers, Suppliers, and Distributors, Government Agencies, Regulatory Bodies, Potential Investors, Research and Development Institutes, End Users and Others

Report Objectives / Segmentation Covered

By Application
  • Pharmaceuticals
  • Cosmetics
  • Chemicals
By Purity
  • 97%
  • >98%
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Disposable Income of the Global Population
      • 3.2.2. Growing Demand for Eye Care Creams
    • 3.3. Market Challenges
      • 3.3.1. Complications Associated with Use of N-Hydroxysuccinimide in Peptide Synthesis
    • 3.4. Market Trends
      • 3.4.1. Surge in Need for Quality Cosmetics Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global N-Hydroxysuccinimide, by Application, Purity and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global N-Hydroxysuccinimide (Value)
      • 5.2.1. Global N-Hydroxysuccinimide by: Application (Value)
        • 5.2.1.1. Pharmaceuticals
        • 5.2.1.2. Cosmetics
        • 5.2.1.3. Chemicals
      • 5.2.2. Global N-Hydroxysuccinimide by: Purity (Value)
        • 5.2.2.1. 97%
        • 5.2.2.2. >98%
        • 5.2.2.3. Others
      • 5.2.3. Global N-Hydroxysuccinimide Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global N-Hydroxysuccinimide (Volume)
      • 5.3.1. Global N-Hydroxysuccinimide by: Application (Volume)
        • 5.3.1.1. Pharmaceuticals
        • 5.3.1.2. Cosmetics
        • 5.3.1.3. Chemicals
      • 5.3.2. Global N-Hydroxysuccinimide by: Purity (Volume)
        • 5.3.2.1. 97%
        • 5.3.2.2. >98%
        • 5.3.2.3. Others
      • 5.3.3. Global N-Hydroxysuccinimide Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global N-Hydroxysuccinimide (Price)
  • 6. N-Hydroxysuccinimide: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Apollo Scientific Ltd (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Alfa Aesar, (Thermo Fisher Scientific) (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Capot Chemical Co., Ltd. (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Glentham Life Sciences Ltd (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. VWR International, LLC. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Actylis (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Suzhou Highfine Biotech Co., Ltd (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. RX Chemicals (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Glentham Life Sciences Ltd (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Jigs Chemical Limited (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. AdipoGen Life Sciences (Switzerland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd (China)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global N-Hydroxysuccinimide Sale, by Application, Purity and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global N-Hydroxysuccinimide (Value)
      • 7.2.1. Global N-Hydroxysuccinimide by: Application (Value)
        • 7.2.1.1. Pharmaceuticals
        • 7.2.1.2. Cosmetics
        • 7.2.1.3. Chemicals
      • 7.2.2. Global N-Hydroxysuccinimide by: Purity (Value)
        • 7.2.2.1. 97%
        • 7.2.2.2. >98%
        • 7.2.2.3. Others
      • 7.2.3. Global N-Hydroxysuccinimide Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global N-Hydroxysuccinimide (Volume)
      • 7.3.1. Global N-Hydroxysuccinimide by: Application (Volume)
        • 7.3.1.1. Pharmaceuticals
        • 7.3.1.2. Cosmetics
        • 7.3.1.3. Chemicals
      • 7.3.2. Global N-Hydroxysuccinimide by: Purity (Volume)
        • 7.3.2.1. 97%
        • 7.3.2.2. >98%
        • 7.3.2.3. Others
      • 7.3.3. Global N-Hydroxysuccinimide Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global N-Hydroxysuccinimide (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. N-Hydroxysuccinimide: by Application(USD Million)
  • Table 2. N-Hydroxysuccinimide Pharmaceuticals , by Region USD Million (2016-2021)
  • Table 3. N-Hydroxysuccinimide Cosmetics , by Region USD Million (2016-2021)
  • Table 4. N-Hydroxysuccinimide Chemicals , by Region USD Million (2016-2021)
  • Table 5. N-Hydroxysuccinimide: by Purity(USD Million)
  • Table 6. N-Hydroxysuccinimide 97% , by Region USD Million (2016-2021)
  • Table 7. N-Hydroxysuccinimide >98% , by Region USD Million (2016-2021)
  • Table 8. N-Hydroxysuccinimide Others , by Region USD Million (2016-2021)
  • Table 9. South America N-Hydroxysuccinimide, by Country USD Million (2016-2021)
  • Table 10. South America N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 11. South America N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 12. Brazil N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 13. Brazil N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 14. Argentina N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 15. Argentina N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 16. Rest of South America N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 17. Rest of South America N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 18. Asia Pacific N-Hydroxysuccinimide, by Country USD Million (2016-2021)
  • Table 19. Asia Pacific N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 20. Asia Pacific N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 21. China N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 22. China N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 23. Japan N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 24. Japan N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 25. India N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 26. India N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 27. South Korea N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 28. South Korea N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 29. Taiwan N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 30. Taiwan N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 31. Australia N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 32. Australia N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 33. Rest of Asia-Pacific N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 34. Rest of Asia-Pacific N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 35. Europe N-Hydroxysuccinimide, by Country USD Million (2016-2021)
  • Table 36. Europe N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 37. Europe N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 38. Germany N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 39. Germany N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 40. France N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 41. France N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 42. Italy N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 43. Italy N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 44. United Kingdom N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 45. United Kingdom N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 46. Netherlands N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 47. Netherlands N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 48. Rest of Europe N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 49. Rest of Europe N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 50. MEA N-Hydroxysuccinimide, by Country USD Million (2016-2021)
  • Table 51. MEA N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 52. MEA N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 53. Middle East N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 54. Middle East N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 55. Africa N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 56. Africa N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 57. North America N-Hydroxysuccinimide, by Country USD Million (2016-2021)
  • Table 58. North America N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 59. North America N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 60. United States N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 61. United States N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 62. Canada N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 63. Canada N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 64. Mexico N-Hydroxysuccinimide, by Application USD Million (2016-2021)
  • Table 65. Mexico N-Hydroxysuccinimide, by Purity USD Million (2016-2021)
  • Table 66. N-Hydroxysuccinimide Sales: by Application(K Tons)
  • Table 67. N-Hydroxysuccinimide Sales Pharmaceuticals , by Region K Tons (2016-2021)
  • Table 68. N-Hydroxysuccinimide Sales Cosmetics , by Region K Tons (2016-2021)
  • Table 69. N-Hydroxysuccinimide Sales Chemicals , by Region K Tons (2016-2021)
  • Table 70. N-Hydroxysuccinimide Sales: by Purity(K Tons)
  • Table 71. N-Hydroxysuccinimide Sales 97% , by Region K Tons (2016-2021)
  • Table 72. N-Hydroxysuccinimide Sales >98% , by Region K Tons (2016-2021)
  • Table 73. N-Hydroxysuccinimide Sales Others , by Region K Tons (2016-2021)
  • Table 74. South America N-Hydroxysuccinimide Sales, by Country K Tons (2016-2021)
  • Table 75. South America N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 76. South America N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 77. Brazil N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 78. Brazil N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 79. Argentina N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 80. Argentina N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 81. Rest of South America N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 82. Rest of South America N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 83. Asia Pacific N-Hydroxysuccinimide Sales, by Country K Tons (2016-2021)
  • Table 84. Asia Pacific N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 85. Asia Pacific N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 86. China N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 87. China N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 88. Japan N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 89. Japan N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 90. India N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 91. India N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 92. South Korea N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 93. South Korea N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 94. Taiwan N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 95. Taiwan N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 96. Australia N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 97. Australia N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 98. Rest of Asia-Pacific N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 99. Rest of Asia-Pacific N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 100. Europe N-Hydroxysuccinimide Sales, by Country K Tons (2016-2021)
  • Table 101. Europe N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 102. Europe N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 103. Germany N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 104. Germany N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 105. France N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 106. France N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 107. Italy N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 108. Italy N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 109. United Kingdom N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 110. United Kingdom N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 111. Netherlands N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 112. Netherlands N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 113. Rest of Europe N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 114. Rest of Europe N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 115. MEA N-Hydroxysuccinimide Sales, by Country K Tons (2016-2021)
  • Table 116. MEA N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 117. MEA N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 118. Middle East N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 119. Middle East N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 120. Africa N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 121. Africa N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 122. North America N-Hydroxysuccinimide Sales, by Country K Tons (2016-2021)
  • Table 123. North America N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 124. North America N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 125. United States N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 126. United States N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 127. Canada N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 128. Canada N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 129. Mexico N-Hydroxysuccinimide Sales, by Application K Tons (2016-2021)
  • Table 130. Mexico N-Hydroxysuccinimide Sales, by Purity K Tons (2016-2021)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. N-Hydroxysuccinimide: by Application(USD Million)
  • Table 144. N-Hydroxysuccinimide Pharmaceuticals , by Region USD Million (2022-2027)
  • Table 145. N-Hydroxysuccinimide Cosmetics , by Region USD Million (2022-2027)
  • Table 146. N-Hydroxysuccinimide Chemicals , by Region USD Million (2022-2027)
  • Table 147. N-Hydroxysuccinimide: by Purity(USD Million)
  • Table 148. N-Hydroxysuccinimide 97% , by Region USD Million (2022-2027)
  • Table 149. N-Hydroxysuccinimide >98% , by Region USD Million (2022-2027)
  • Table 150. N-Hydroxysuccinimide Others , by Region USD Million (2022-2027)
  • Table 151. South America N-Hydroxysuccinimide, by Country USD Million (2022-2027)
  • Table 152. South America N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 153. South America N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 154. Brazil N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 155. Brazil N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 156. Argentina N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 157. Argentina N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 158. Rest of South America N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 159. Rest of South America N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 160. Asia Pacific N-Hydroxysuccinimide, by Country USD Million (2022-2027)
  • Table 161. Asia Pacific N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 162. Asia Pacific N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 163. China N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 164. China N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 165. Japan N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 166. Japan N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 167. India N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 168. India N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 169. South Korea N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 170. South Korea N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 171. Taiwan N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 172. Taiwan N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 173. Australia N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 174. Australia N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 175. Rest of Asia-Pacific N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 176. Rest of Asia-Pacific N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 177. Europe N-Hydroxysuccinimide, by Country USD Million (2022-2027)
  • Table 178. Europe N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 179. Europe N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 180. Germany N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 181. Germany N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 182. France N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 183. France N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 184. Italy N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 185. Italy N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 186. United Kingdom N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 187. United Kingdom N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 188. Netherlands N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 189. Netherlands N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 190. Rest of Europe N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 191. Rest of Europe N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 192. MEA N-Hydroxysuccinimide, by Country USD Million (2022-2027)
  • Table 193. MEA N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 194. MEA N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 195. Middle East N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 196. Middle East N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 197. Africa N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 198. Africa N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 199. North America N-Hydroxysuccinimide, by Country USD Million (2022-2027)
  • Table 200. North America N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 201. North America N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 202. United States N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 203. United States N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 204. Canada N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 205. Canada N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 206. Mexico N-Hydroxysuccinimide, by Application USD Million (2022-2027)
  • Table 207. Mexico N-Hydroxysuccinimide, by Purity USD Million (2022-2027)
  • Table 208. N-Hydroxysuccinimide Sales: by Application(K Tons)
  • Table 209. N-Hydroxysuccinimide Sales Pharmaceuticals , by Region K Tons (2022-2027)
  • Table 210. N-Hydroxysuccinimide Sales Cosmetics , by Region K Tons (2022-2027)
  • Table 211. N-Hydroxysuccinimide Sales Chemicals , by Region K Tons (2022-2027)
  • Table 212. N-Hydroxysuccinimide Sales: by Purity(K Tons)
  • Table 213. N-Hydroxysuccinimide Sales 97% , by Region K Tons (2022-2027)
  • Table 214. N-Hydroxysuccinimide Sales >98% , by Region K Tons (2022-2027)
  • Table 215. N-Hydroxysuccinimide Sales Others , by Region K Tons (2022-2027)
  • Table 216. South America N-Hydroxysuccinimide Sales, by Country K Tons (2022-2027)
  • Table 217. South America N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 218. South America N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 219. Brazil N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 220. Brazil N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 221. Argentina N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 222. Argentina N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 223. Rest of South America N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 224. Rest of South America N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 225. Asia Pacific N-Hydroxysuccinimide Sales, by Country K Tons (2022-2027)
  • Table 226. Asia Pacific N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 227. Asia Pacific N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 228. China N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 229. China N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 230. Japan N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 231. Japan N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 232. India N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 233. India N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 234. South Korea N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 235. South Korea N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 236. Taiwan N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 237. Taiwan N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 238. Australia N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 239. Australia N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 240. Rest of Asia-Pacific N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 241. Rest of Asia-Pacific N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 242. Europe N-Hydroxysuccinimide Sales, by Country K Tons (2022-2027)
  • Table 243. Europe N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 244. Europe N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 245. Germany N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 246. Germany N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 247. France N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 248. France N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 249. Italy N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 250. Italy N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 251. United Kingdom N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 252. United Kingdom N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 253. Netherlands N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 254. Netherlands N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 255. Rest of Europe N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 256. Rest of Europe N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 257. MEA N-Hydroxysuccinimide Sales, by Country K Tons (2022-2027)
  • Table 258. MEA N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 259. MEA N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 260. Middle East N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 261. Middle East N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 262. Africa N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 263. Africa N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 264. North America N-Hydroxysuccinimide Sales, by Country K Tons (2022-2027)
  • Table 265. North America N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 266. North America N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 267. United States N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 268. United States N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 269. Canada N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 270. Canada N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 271. Mexico N-Hydroxysuccinimide Sales, by Application K Tons (2022-2027)
  • Table 272. Mexico N-Hydroxysuccinimide Sales, by Purity K Tons (2022-2027)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global N-Hydroxysuccinimide: by Application USD Million (2016-2021)
  • Figure 5. Global N-Hydroxysuccinimide: by Purity USD Million (2016-2021)
  • Figure 6. South America N-Hydroxysuccinimide Share (%), by Country
  • Figure 7. Asia Pacific N-Hydroxysuccinimide Share (%), by Country
  • Figure 8. Europe N-Hydroxysuccinimide Share (%), by Country
  • Figure 9. MEA N-Hydroxysuccinimide Share (%), by Country
  • Figure 10. North America N-Hydroxysuccinimide Share (%), by Country
  • Figure 11. Global N-Hydroxysuccinimide: by Application K Tons (2016-2021)
  • Figure 12. Global N-Hydroxysuccinimide: by Purity K Tons (2016-2021)
  • Figure 13. South America N-Hydroxysuccinimide Share (%), by Country
  • Figure 14. Asia Pacific N-Hydroxysuccinimide Share (%), by Country
  • Figure 15. Europe N-Hydroxysuccinimide Share (%), by Country
  • Figure 16. MEA N-Hydroxysuccinimide Share (%), by Country
  • Figure 17. North America N-Hydroxysuccinimide Share (%), by Country
  • Figure 18. Global N-Hydroxysuccinimide share by Players 2021 (%)
  • Figure 19. Global N-Hydroxysuccinimide share by Players (Top 3) 2021(%)
  • Figure 20. Global N-Hydroxysuccinimide share by Players (Top 5) 2021(%)
  • Figure 21. BCG Matrix for key Companies
  • Figure 22. Apollo Scientific Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. Apollo Scientific Ltd (United Kingdom) Revenue: by Geography 2021
  • Figure 24. Alfa Aesar, (Thermo Fisher Scientific) (United States) Revenue, Net Income and Gross profit
  • Figure 25. Alfa Aesar, (Thermo Fisher Scientific) (United States) Revenue: by Geography 2021
  • Figure 26. Capot Chemical Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 27. Capot Chemical Co., Ltd. (China) Revenue: by Geography 2021
  • Figure 28. Glentham Life Sciences Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Glentham Life Sciences Ltd (United Kingdom) Revenue: by Geography 2021
  • Figure 30. VWR International, LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 31. VWR International, LLC. (United States) Revenue: by Geography 2021
  • Figure 32. Actylis (United States) Revenue, Net Income and Gross profit
  • Figure 33. Actylis (United States) Revenue: by Geography 2021
  • Figure 34. Suzhou Highfine Biotech Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 35. Suzhou Highfine Biotech Co., Ltd (China) Revenue: by Geography 2021
  • Figure 36. RX Chemicals (India) Revenue, Net Income and Gross profit
  • Figure 37. RX Chemicals (India) Revenue: by Geography 2021
  • Figure 38. Glentham Life Sciences Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 39. Glentham Life Sciences Ltd (United Kingdom) Revenue: by Geography 2021
  • Figure 40. Jigs Chemical Limited (India) Revenue, Net Income and Gross profit
  • Figure 41. Jigs Chemical Limited (India) Revenue: by Geography 2021
  • Figure 42. AdipoGen Life Sciences (Switzerland) Revenue, Net Income and Gross profit
  • Figure 43. AdipoGen Life Sciences (Switzerland) Revenue: by Geography 2021
  • Figure 44. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 45. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd (China) Revenue: by Geography 2021
  • Figure 46. Global N-Hydroxysuccinimide: by Application USD Million (2022-2027)
  • Figure 47. Global N-Hydroxysuccinimide: by Purity USD Million (2022-2027)
  • Figure 48. South America N-Hydroxysuccinimide Share (%), by Country
  • Figure 49. Asia Pacific N-Hydroxysuccinimide Share (%), by Country
  • Figure 50. Europe N-Hydroxysuccinimide Share (%), by Country
  • Figure 51. MEA N-Hydroxysuccinimide Share (%), by Country
  • Figure 52. North America N-Hydroxysuccinimide Share (%), by Country
  • Figure 53. Global N-Hydroxysuccinimide: by Application K Tons (2022-2027)
  • Figure 54. Global N-Hydroxysuccinimide: by Purity K Tons (2022-2027)
  • Figure 55. South America N-Hydroxysuccinimide Share (%), by Country
  • Figure 56. Asia Pacific N-Hydroxysuccinimide Share (%), by Country
  • Figure 57. Europe N-Hydroxysuccinimide Share (%), by Country
  • Figure 58. MEA N-Hydroxysuccinimide Share (%), by Country
  • Figure 59. North America N-Hydroxysuccinimide Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Apollo Scientific Ltd (United Kingdom)
  • Alfa Aesar, (Thermo Fisher Scientific) (United States)
  • Capot Chemical Co., Ltd. (China)
  • Glentham Life Sciences Ltd (United Kingdom)
  • VWR International, LLC. (United States)
  • Actylis (United States)
  • Suzhou Highfine Biotech Co., Ltd (China)
  • RX Chemicals (India)
  • Glentham Life Sciences Ltd (United Kingdom)
  • Jigs Chemical Limited (India)
  • AdipoGen Life Sciences (Switzerland)
  • Hefei Home Sunshine Pharmaceutical Technology Co., Ltd (China)
Select User Access Type

Key Highlights of Report


Feb 2023 212 Pages 64 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2027
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • Complications Associated with Use of N-Hydroxysuccinimide in Peptide Synthesis

Know More About Global N-Hydroxysuccinimide Market Report?